A Phase 4 interventional study of Povidone-Iodine and 4% Chlorhexidine Gluconate in Surgical Preparation of the Vagina, sponsored by Northwestern University. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-06-27.
Sponsored by Northwestern University · Phase 4, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Conduct a randomized control study to compare the tolerance of 4% chlorhexidine gluconate/4% isopropyl alcohol versus povidone iodine vaginal cleansing solutions for surgical preparations of the vagina. Patients will be randomized to either control (povidone iodine) or experimental (chlorhexidine gluconate), and then be given a short survey prior to and immediately after surgery, and again 24-48 hours via phone asking them about the presence and severity of vaginal dryness, burning, itchiness, unusual vaginal discharge, and pain or burning with urination.
Surgical site antisepsis is critical in preventing surgical site infections. Although chlorhexidine gluconate has proven to be superior to povidone iodine for surgical site antisepsis, povidone iodine is the only FDA-approved antiseptic solution for surgical preparation of the vagina. Many surgeons are hesitant to use chlorhexidine gluconate for preoperative vaginal cleansing due to the alcohol dissolvent present in the solutions that is implicated in a greater risk of irritation. Yet, there has been no randomized study to illustrate whether the risk of vaginal irritation is greater in chlorhexidine gluconate versus povidone iodine. Thus, the purpose of the study is to conduct a randomized control trial to compare the tolerance of 4% chlorhexidine gluconate to povidone iodine using patient-reported outcomes of vaginal or urinary symptoms. Patients will be randomized to either control or experimental, and then be given a short survey prior to and immediately after surgery, and again 24-48 hours via phone asking them about the presence and severity of vaginal dryness, burning, itchiness, unusual vaginal discharge, and pain or burning with urination.
Northwestern University is the lead sponsor of 1,424 studies on the registry; 199 are open to participants now.
Of its 105 completed or terminated interventional studies of FDA-regulated products, 78 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients to receive povidone iodine for the surgical preparation of the vagina.
Drug: Povidone-Iodine
Patients to receive 4% chlorhexidine gluconate for the surgical preparation of the vagina.
Drug: 4% Chlorhexidine Gluconate
Patients will receive povidone iodine for the surgical preparation of the vagina.
Patients will receive 4% chlorhexidine gluconate for the surgical preparation of the vagina.
Number of Participants With Vaginal or Urinary Symptoms After Surgery, Assessed by Validated Questionnaire (Modified PRO-CTCAE)
To determine and compare the number of participants with vaginal or urinary symptoms after treatment with chlorhexidine gluconate versus povidone iodine vaginal cleansing solutions.
Time frame: Day of surgery to 24-48 hours after surgery
| Milestone | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) |
|---|---|---|
| Started | 66 | 68 |
| Completed | 63 | 60 |
| Not completed | 3 | 8 |
To determine and compare the number of participants with vaginal or urinary symptoms after treatment with chlorhexidine gluconate versus povidone iodine vaginal cleansing solutions.
| Participants | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) |
|---|---|---|
| Vaginal dryness | 4 | 11 |
| Vaginal burning | 8 | 25 |
| Unusual vaginal discharge | 10 | 14 |
| Pain of burning with urination | 9 | 17 |
| Vaginal itchiness | 7 | 7 |
Collected over Data were collected for each patient immediately postoperatively to 24-48 hours postoperatively.. Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Control (Povidone Iodine) | 0/63 (0%) | 0/63 (0%) | 0/63 (0%) |
| Intervention (4% Chlorhexidine Gluconate) | 0/60 (0%) | 0/60 (0%) | 1/59 (1.7%) |
| Event | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) |
|---|---|---|
| Severe SwellingSkin and subcutaneous tissue disorders | 0/63 | 1/59 |
| Age, Categorical(Participants) | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) | Total |
|---|---|---|---|
| <=18 years | 0 | 0 | 0 |
| Between 18 and 65 years | 59 | 59 | 118 |
| >=65 years | 4 | 1 | 5 |
| Age, Continuous(years) | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) | Total |
|---|---|---|---|
| Mean | 46 ± 10 | 44 ± 9 | 45 ± 9.7 |
| Sex: Female, Male(Participants) | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) | Total |
|---|---|---|---|
| Female | 63 | 60 | 123 |
| Male | 0 | 0 | 0 |
| Race (NIH/OMB)(Participants) | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) | Total |
|---|---|---|---|
| American Indian or Alaska Native | 0 | 0 | 0 |
| Asian | 4 | 2 | 6 |
| Native Hawaiian or Other Pacific Islander | 0 | 0 | 0 |
| Black or African American | 8 | 9 | 17 |
| White | 41 | 39 | 80 |
| More than one race | 0 | 0 | 0 |
| Unknown or Not Reported | 10 | 10 | 20 |
| Region of Enrollment(participants) | Control (Povidone Iodine) | Intervention (4% Chlorhexidine Gluconate) | Total |
|---|---|---|---|
| United States | 63 | 60 | 123 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: Undecided
Ran from Aug 2017 to primary completion in Apr 2018, 8 months.
Results were first posted in Jun 2019, 1 year 2 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Chlorhexidine gluconate